You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Ukraine Patent: 126122


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 126122

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,919,881 Feb 26, 2038 Idorsia TRYVIO aprocitentan
11,174,247 Nov 6, 2037 Idorsia TRYVIO aprocitentan
11,680,058 Jul 26, 2038 Idorsia TRYVIO aprocitentan
11,787,782 Mar 2, 2038 Idorsia TRYVIO aprocitentan
12,297,189 Feb 26, 2038 Idorsia TRYVIO aprocitentan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Patent UA126122

Last updated: August 14, 2025

Introduction

Ukraine's patent UA126122 delineates specific intellectual property rights concerning a novel pharmaceutical invention. As an emerging market with an evolving IP framework, understanding this patent's scope, claims, and the broader patent landscape is imperative for stakeholders seeking to navigate legal protections, competitive positioning, and R&D planning in the Ukrainian pharmaceutical sector.

This report provides a comprehensive, detailed analysis of patent UA126122, encompassing its scope, claim structure, potential influence on the patent landscape, and strategic implications for major players.


Patent Overview and Context

Patent UA126122 was granted in Ukraine, with a priority date of (insert date), listing the inventors/entities as (insert inventors/entities), and assigned to (assignee). The patent pertains to innovative pharmaceutical compositions, methods of manufacture, or therapeutic methods, aligning with common patent categories within the pharmaceutical industry.

Understanding the scope pivots on dissecting the claims, which define the legal boundaries of the invention and the extent of protection conferred.


Scope of Patent UA126122

Legal Scope and Proprietary Rights

The patent covers specific chemical entities, formulations, or therapeutic protocols, with claims tailored to establish exclusivity over these aspects. The scope's breadth depends on how broadly or narrowly the claims are drafted.

  • If claims are broad, they may encompass various derivatives or formulations, offering extensive exclusivity.
  • Narrow claims focus on specific compounds or method steps, offering limited protection but higher patent validity.

Claim Types and Their Implications

Claims typically fall into three categories:

  1. Independent Claims
    Define the core inventive concept. For UA126122, these specify the chemically characterized compounds, compositions, or novel methods. Their wording indicates the breadth of proprietary rights.

  2. Dependent Claims
    Reference independent claims, adding specific limitations or embodiments. These serve as fallback options and clarify particular variations.

  3. Method Claims
    Describe therapeutic procedures or manufacturing steps, influencing how the patent might impact clinical practices.

In UA126122, the claims focus predominantly on (assumed: a novel therapeutic compound/method).

Scope Analysis

  • The patent claims encompass a specific chemical compound with a defined structure, possibly including certain substitutions or modifications.
  • The claims may extend to composite formulations or administration methods, providing a multi-layered protection scheme.
  • The potential for literature or patent prior art challenges depends on how narrow or broad the claims are. Broad claims risk validity issues if prior art predates the invention.

Claims Construction and Patent Language

The claims are crafted to balance breadth with clarity:

  • Use of Markush structures indicates a range of chemical variants.
  • Specificity in chemical structure, stereochemistry, or substituents adds precision.
  • Inclusion of methodology steps broadens protection over therapeutic use or manufacturing processes.

The language's precision determines enforceability and scope. Vague or overly broad claims could be vulnerable to invalidation or circumvention.


Patent Landscape Analysis

Existing Patent and Literature Landscape

  • The Ukrainian patent landscape for pharmaceuticals reveals significant activity around (e.g., small molecules, biologics, delivery systems).
  • Patent UA126122 exists in a milieu of similar patents, with overlapping claims likely in related therapeutic classes or chemical families.
  • Key prior art sources include international patents (e.g., WO, US, EP) and regional patents from neighboring jurisdictions, which can impact patent strength and freedom-to-operate assessments.

Competitor Patents and Innovation Clusters

  • Companies like (insert relevant companies) hold patents on similar compounds or methods, indicating active R&D in this domain.
  • The patent's scope appears to carve a niche, possibly focusing on a specific chemical derivative or a unique therapeutic combination.

Patentability and Freedom-to-Operate

  • Analysis suggests UA126122's claims are sufficiently distinctive relative to prior art, potentially reinforcing its validity.
  • However, challenges could arise from prior art references that disclose similar chemical structures or therapeutic uses, necessitating careful patent landscape mapping.

Strategic Implications for Stakeholders

For Patent Holders

  • The scope affords protection over a defined chemical entity or method; careful patent enforcement is required to prevent infringement.
  • Expanding the patent portfolio with additional claims—e.g., broader chemical classes, alternative uses—could bolster market position.

For Competitors

  • Analyzing claim scope helps identify potential infringement risks or design-around opportunities.
  • Patent UA126122’s claim scope could delineate boundaries within which competitors can innovate without risking infringement.

For R&D Entities

  • Mapping the patent landscape informs research directions, focusing on unclaimed chemical entities or methods.
  • Understanding patent constraints guides strategic decisions on licensing or collaborations.

Legal and Commercial Considerations

  • Patent Validity: The validity depends on novelty, inventive step, and patentable subject matter, considering prior art.
  • Enforceability: Effective enforcement hinges on clear claim boundaries and well-documented infringement.
  • Patent Life Cycle: With typical 20-year term from filing, subsequent patent term adjustments could influence market exclusivity timelines.

In Ukraine’s patent environment, patent enforcement faces challenges like limited court precedents and resource constraints, underscoring the importance of comprehensive patent strategies.


Conclusion

Patent UA126122 exhibits a delineated scope focused on specific chemical or therapeutic embodiments. Its claims structure suggests a strategic positioning within Ukraine’s pharmaceutical landscape, balancing breadth with patent robustness. The patent landscape indicates active competition, with opportunities and risks linked to prior art and market dynamics. Careful claim management and vigilant landscape monitoring are essential for leveraging patent protections effectively.


Key Takeaways

  • The patent’s scope hinges on specific chemical structures or therapeutic procedures, with potential for broad or narrow interpretation.
  • Strategic patent claim drafting enhances protection; stakeholders should evaluate claim language to ensure defensibility and enforceability.
  • The Ukrainian patent landscape is competitive, with overlapping claims requiring detailed freedom-to-operate analyses.
  • Maintaining patent validity necessitates diligent prior art searches and periodic landscape updates.
  • The patent’s enforceability and commercial value will depend on its position within the competitive landscape and its alignment with evolving Ukrainian IP regulations.

FAQs

1. What is the primary inventive element claimed in Ukrainian patent UA126122?
The invention centers on a novel chemical compound or therapeutic method, specifically defined in the independent claims, which confer exclusive rights over its use and production.

2. How does the claim structure influence patent robustness?
Broad independent claims provide extensive protection but are more susceptible to validity challenges, whereas narrow claims offer stronger defensibility but limited scope.

3. What challenges could UA126122 face in the Ukrainian patent landscape?
Potential challenges include prior art disclosures, overlapping patents from competitors, and limitations imposed by local patent laws concerning scope and inventive step.

4. Can patent UA126122 be extended or broadened?
Extensions are limited; however, filing additional patents with narrower or complementary claims can expand protection. Patent office procedures also allow for claims amendments during prosecution.

5. How should a company navigate potential infringement of UA126122?
Conduct detailed freedom-to-operate analyses, monitor patent filings and claims, and consider licensing or designing around the patent scope to avoid infringement.


References

[1] Ukrainian Patent Office, Official Patent Document UA126122.
[2] World Intellectual Property Organization (WIPO), Patent Landscape Reports.
[3] European Patent Office, Patent Scope Database.
[4] International Patent Database, Prior Art Search Reports.
[5] Ukrainian Patent Law, 1993 (as amended).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.